Lasers used for painless injections; RXi and Royal Philips ink delivery pact;

CNET reviews Pantec's new Painless Laser Epidermal System, which uses lasers to create micropores in the skin, doing away with injections. Medical professionals can adjust the delivery device for diabetics to use at home, and there's a desktop unit that can be used in the clinic for faster injections. Story

> RXi and Royal Philips are partnering, matching RXi's RNAi compounds with Royal's ultrasound tech to monitor and deliver the compounds. Report

> ULURU, which is working on the improved delivery of a portfolio of wound management and oral care products, announced the resignation of CEO Renaat Van den Hooff. Release

> Hospira has inked a licensing pact with Durect for Posidur, a long-acting version of the anesthetic bupivacaine currently in Phase III clinical trials. Release

> The drug delivery specialist Vectura says it is closing in on a pact to market its generic asthma drug in the U.S. The U.K. developer also said it has three new products being readied for the clinic. Report

Suggested Articles

The new digital Abilify is a breakthrough for Proteus Digital Health and its patient-tracking products, but not so much for Abilify's maker, Otsuka.

Adamis Pharmaceuticals' EpiPen contender Symjepi, which was rejected last year before the EpiPen havoc, won approval from the FDA.

Researchers in the U.K. have developed a technique to better predict results in liver cancer when drug-laden polymer beads are used to deliver medicines.